levetiracetam- levetiracetam tablet, film coated
trigen laboratories, inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of primary generalized tonicoclonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.
levetiracetam injection, solution, concentrate
sagent pharmaceuticals - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg in 5 ml - levetiracetam injection is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. levetiracetam injection is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam injection is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. levetiracetam injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible. levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.3)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), including levetiracetam, during pregnancy. encourage women who are taking le
equibactin vet. (333 mg/g + 67 mg/g) oral paste for horses
le vet bv - trimethoprim; sulfadiazine - oral paste - 66.7, 333.3 milligram(s)/gram - sulfadiazine and trimethoprim - horses - antibacterial
clavubactin s 62.5 mg broad spectrum antibiotic tablets
le vet beheer b. v. - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 50.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 12.5 mg/tb - antibiotic & related - dog - small or toy | dog - small | dog - toy - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
clavubactin m 312.5 mg broad spectrum antibiotic tablets
le vet beheer b. v. - amoxycillin (as the trihydrate); clavulanic acid as potassium clavulanate - oral tablet - amoxycillin (as the trihydrate) antibiotic active 250.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 62.5 mg/tb - antibiotic & related - dog - medium | castrate - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
levetiracetam solution
alembic pharmaceuticals inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. information describing the use of levetiracetam in pediatric patients less than 4 years of age as adjunctive therapy in the treatment of partial onset seizures is approved for ucb, inc.'s levetiracetam tablets and oral solution. however, due to ucb, inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam.
phenoleptil 100 mg tablets for dogs
le vet bv - phenobarbital - tablet - 100 mg/tablet - phenobarbital - dogs - neurological preparations
phenoleptil 25 mg tablets for dogs
le vet bv - phenobarbital - tablet - 25 mg/tablet - phenobarbital - dogs - neurological preparations
phenoleptil 12.5 mg tablets for dogs
le vet bv - phenobarbital - tablet - 12.5 mg/tablet - phenobarbital - dogs - neurological preparations
phenoleptil 50 mg tablets for dogs
le vet bv - phenobarbital - tablet - 50 mg/tablet - phenobarbital - dogs - neurological preparations